在癌症调控和进展中的瘤神经相互作用
Jianyi Zhao1, Lilin Cheng2, Jian Yang3
1Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China; Shanghai Key Laboratory of Proton-Therapy, Shanghai, 201801, China.
Cancer letters
|January 22, 2025
概括
瘤神经相互作用显著影响癌症的进展和治疗耐药性. 重用神经系统药物为癌症患者提供了新的治疗策略.
科学领域:
- 神经科学和瘤学
- 癌症生物学 癌症生物学
- 瘤微环境 瘤微环境
背景情况:
- 瘤神经相互作用对于癌症的进展,转移和治疗耐药性至关重要.
- 人们越来越认识到神经系统在癌症生物学中的作用,它会影响瘤微环境的动态.
研究的目的:
- 综合审查神经系统参与癌症的机制.
- 探索用于癌症治疗的神经系统向药物的重新用途的潜力.
- 确定将这些发现转化为临床实践的挑战和机会.
主要方法:
- 关于瘤神经相互作用研究的综合文献综述.
- 分析包括神经入侵,免疫逃避和瘤适应在内的机制.
- 评估现有的实验模型和临床翻译挑战.
主要成果:
- 周围和中枢神经系统积极促进癌症的进展.
- 针对神经系统的药物显示出创新癌症治疗的潜力.
- 目前的实验模型和临床翻译存在重大挑战.
结论:
- 了解瘤神经相互作用对于推进癌症治疗至关重要.
- 对神经退行性和自身免疫性疾病的药物的重新定位为瘤学提供了一个有前途的途径.
- 桥梁神经科学和瘤学可以导致新的治疗策略,以改善患者的治疗结果.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer
47.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.7K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


